Correlation Between Oncorus and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oncorus and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Oncorus and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Quoin Pharmaceuticals.
Diversification Opportunities for Oncorus and Quoin Pharmaceuticals
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Oncorus and Quoin is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Oncorus i.e., Oncorus and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Oncorus and Quoin Pharmaceuticals
If you would invest 68.00 in Quoin Pharmaceuticals Ltd on September 2, 2024 and sell it today you would lose (8.00) from holding Quoin Pharmaceuticals Ltd or give up 11.76% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
Oncorus vs. Quoin Pharmaceuticals Ltd
Performance |
Timeline |
Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Quoin Pharmaceuticals |
Oncorus and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncorus and Quoin Pharmaceuticals
The main advantage of trading using opposite Oncorus and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Neurobo Pharmaceuticals | Quoin Pharmaceuticals vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |